Patent US3987201A successfully refreshed from Google Patents.
US3987201A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for treating arrhythmia
Assignee: Eli Lilly and Co
•
Filing: 1974-12-24
•
Granted: 1976-10-19
•
Expires: 1994-12-24
Abstract
Abstract Cardiac arrhythmia is treated orally or parenterally with diarylalkylamines and diarylalkenylamines.
Inventors
- 👤 Bryan B. Molloy
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 19:28
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/13; A61K31/135
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
115 words
A method for treating arrhythmia comprising administering to a subject suffering from an arrhythmia and in need of treatment an effective amount of a compound of the formula ##SPC2## wherein: n is 1, 2, or 3; m is 0, 1, 2, or 3; q is 0 or 2; and m plus n is greater than 1 and less than 6; X is hydrogen, fluorine, chlorine, bromine, or iodine; Y and Z each are hydrogen or, taken together, form a double bond; R 1 and R 2 independently are hydrogen, C 1 --C 6 alkyl, or --CH 2 R 3 ; wherein: R 3 is C 2 --C 5 alkenyl; and the pharmaceutically acceptable salts thereof.
Claim 2
Independent Claim
115 words
A method for treating arrhythmia comprising administering to a subject suffering from an arrhythmia and in need of treatment an effective amount of a compound of the formula ##SPC2## wherein: n is 1, 2, or 3; m is 0, 1, 2, or 3; q is 0 or 2; and m plus n is greater than 1 and less than 6; X is hydrogen, fluorine, chlorine, bromine, or iodine; Y and Z each are hydrogen or, taken together, form a double bond; R 1 and R 2 independently are hydrogen, C 1 --C 6 alkyl, or --CH 2 R 3 ; wherein: R 3 is C 2 --C 5 alkenyl; and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
23 words
The method according to claim 1 wherein in the formula representing the compound administered, q is 0 and X is hydrogen or fluorine.
Claim 4
Dependent Claim
17 words
The method according to claim 2 wherein in the formula representing the compound administered, m is 0.
Claim 5
Dependent Claim
17 words
The method according to claim 3 wherein in the formula representing the compound administered, n is 2.
Claim 6
Dependent Claim
17 words
The method according to claim 4 wherein in the formula representing the compound administered, X is hydrogen.
Claim 7
Dependent Claim
21 words
The method according to claim 5 wherein in the formula representing the compound being administered, Y and Z each are hydrogen.
Claim 8
Dependent Claim
27 words
The method according to claim 6 wherein in the formula representing the compound being administered, R 1 and R 2 independently are C 1 --C 6 alkyl.
Claim 9
Dependent Claim
12 words
The method according to claim 1 wherein the compound is administered orally.
Claim 10
Dependent Claim
12 words
The method according to claim 1 wherein the compound is administered parenterally.
References Cited (Backward Citations)
US2410469A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1979-10-19 | 1980-04-19 | 1980-10-19 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1983-10-19 | 1984-04-19 | 1984-10-19 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1987-10-19 | 1988-04-19 | 1988-10-19 | $7700.00 | Window Closed / Lapsed |